Advertisement
Canada markets closed
  • S&P/TSX

    21,942.16
    +148.26 (+0.68%)
     
  • S&P 500

    5,482.87
    +4.97 (+0.09%)
     
  • DOW

    39,164.06
    +36.26 (+0.09%)
     
  • CAD/USD

    0.7302
    +0.0003 (+0.04%)
     
  • CRUDE OIL

    81.81
    +0.91 (+1.12%)
     
  • Bitcoin CAD

    84,155.09
    +694.51 (+0.83%)
     
  • CMC Crypto 200

    1,281.85
    +15.70 (+1.24%)
     
  • GOLD FUTURES

    2,338.70
    +25.50 (+1.10%)
     
  • RUSSELL 2000

    2,038.34
    +20.22 (+1.00%)
     
  • 10-Yr Bond

    4.2880
    -0.0280 (-0.65%)
     
  • NASDAQ futures

    20,067.50
    +55.00 (+0.27%)
     
  • VOLATILITY

    12.24
    -0.31 (-2.47%)
     
  • FTSE

    8,179.68
    -45.65 (-0.55%)
     
  • NIKKEI 225

    39,341.54
    -325.53 (-0.82%)
     
  • CAD/EUR

    0.6818
    -0.0013 (-0.19%)
     

Is Now The Time To Look At Buying Omnicell, Inc. (NASDAQ:OMCL)?

While Omnicell, Inc. (NASDAQ:OMCL) might not have the largest market cap around , it saw significant share price movement during recent months on the NASDAQGS, rising to highs of US$32.65 and falling to the lows of US$26.27. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Omnicell's current trading price of US$28.26 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Omnicell’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

View our latest analysis for Omnicell

What's The Opportunity In Omnicell?

Great news for investors – Omnicell is still trading at a fairly cheap price. Our valuation model shows that the intrinsic value for the stock is $38.62, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. Omnicell’s share price also seems relatively stable compared to the rest of the market, as indicated by its low beta. If you believe the share price should eventually reach its true value, a low beta could suggest it is unlikely to rapidly do so anytime soon, and once it’s there, it may be hard to fall back down into an attractive buying range.

Can we expect growth from Omnicell?

earnings-and-revenue-growth
earnings-and-revenue-growth

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. In the upcoming year, Omnicell's earnings are expected to increase by 79%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

What This Means For You

Are you a shareholder? Since OMCL is currently undervalued, it may be a great time to increase your holdings in the stock. With an optimistic outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation.

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping an eye on OMCL for a while, now might be the time to make a leap. Its prosperous future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy OMCL. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed buy.

Diving deeper into the forecasts for Omnicell mentioned earlier will help you understand how analysts view the stock going forward. At Simply Wall St, we have the analysts estimates which you can view by clicking here.

If you are no longer interested in Omnicell, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com